← Back to catalogue

CoaguChek Vantus System

FDA UDI

Class II (US FDA UDI)

by Roche Diagnostics Corp.

Identity

Trade Name
CoaguChek Vantus System FDA UDI
Generic Name
Cancer antigen 15-3 (CA15-3) IVD, antibody FDA UDI
Device Name
CoaguChek Vantus (USA) FDA UDI
Model / Reference
07729952160 FDA UDI
Description
CoaguChek Vantus (USA) FDA UDI

Identifiers

Catalog Number
07729952160 FDA UDI
Primary DI / UDI-DI
00365702700499 FDA UDI
510(k) Number
K170960 FDA UDI
FDA Product Code
GJS FDA UDI
GMDN Term
Cancer antigen 15-3 (CA15-3) IVD, antibody FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
864.7750 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Cancer antigen 15-3 (CA15-3) IVD, antibody

CoaguChek Vantus System by Roche Diagnostics Corp. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Cancer antigen 15-3 (CA15-3) IVD, antibody.

Cleared under the same submission

K170960 also covers:

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI bb54ed57-7e61-4d5f-b47f-25fa5b73fa96 36 fields · synced May 30, 2026